Close

Nektar Therapeutics (NKTR) Offers Additional Detail on Bristol-Myers Squibb Collaboration

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP
6. SPY
7. PI
8. BSX
9. ALGN
10. BIIB


Go back to Nektar Therapeutics (NKTR) Offers Additional Detail on Bristol-Myers Squibb Collaboration

Nektar Therapeutics (NKTR) Sees Early Weakness

September 27, 2016 9:50 AM EDT

Nektar Therapeutics (NASDAQ: NKTR) is under heavy pressure this morning. Shares are down 8.6% on volume that is running 49x normal.

This morning, Bristol-Myers Squibb Company (NYSE: BMY) and Nektar Therapeutics... More

Bristol-Myers Squibb (BMY), Nektar Therapeutics (NKTR) to Evaluate Opdivo + NKTR-214 Combo

September 27, 2016 7:11 AM EDT

Bristol-Myers Squibb Company (NYSE: BMY) and Nektar Therapeutics (Nasdaq:... More